Regadenoson

Category: Heart (Cardiac)



Regadenoson Overview

Regadenoson, sold under the brand name Lexiscan among others, is an A2A adenosine receptor agonist that is a coronary vasodilator that is commonly used in pharmacologic stress testing. It produces hyperemia quickly and maintains it for a duration that is useful for radionuclide myocardial perfusion imaging.[1] The selective nature of the drug makes it preferable to other stress agents such as adenosine, which are less selective and therefore cause more side-effects. Regadenoso...

Read more Regadenoson Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Regadenoson

Recent Regadenoson Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Regadenoson
  • Injection: 0.4mg/5ml (0.08mg/ml)
  • Solution: 0.4mg/5ml (0.08mg/ml)
  • Syringe: 0.4mg/5ml
  • Vial: 0.4mg/5ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Regadenoson: (1 result)

Sorted by National Drug Code
  • 51662-1448 Lexiscan(r) (Regadenoson) .08 mg/ml Intravenous Injection, Solution by Hf Acquisition Co LLC, Dba Healthfirst

Other drugs which contain Regadenoson or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 26 November 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA